3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Plasmacytoma
1
Nasopharyngeal Carcinoma
1
Meningeal Carcinomatosis
1
Lymphoma
1
Liver Neoplasms
1
Glioma
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Interventions
apatinib
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrectomy
2
trastuzumab deruxtecan
1
taxane
1
durvalumab
1
disitamab vedotin
1
Taxes
1
SHR-1701
1
S 1 (combination)
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Indocyanine Green
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastric Adenocarcinoma
×
Immunotherapy, Adoptive
×
90 days
×
Clear all
No trials found.